Go Pro

Cooper Companies (COO) Competitors

Cooper Companies logo
$68.51 -2.81 (-3.94%)
Closing price 07/14/2026 04:00 PM Eastern
Extended Trading
$68.68 +0.17 (+0.25%)
As of 05:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

COO vs. ALC, WST, ALGN, MMSI, and ICUI

Should you buy Cooper Companies stock or one of its competitors? MarketBeat compares Cooper Companies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cooper Companies include Alcon (ALC), West Pharmaceutical Services (WST), Align Technology (ALGN), Merit Medical Systems (MMSI), and ICU Medical (ICUI). These companies are all part of the "medical" sector.

How does Cooper Companies compare to Alcon?

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership, media sentiment and risk.

Cooper Companies presently has a consensus target price of $81.85, suggesting a potential upside of 19.47%. Alcon has a consensus target price of $85.12, suggesting a potential upside of 27.17%. Given Alcon's stronger consensus rating and higher probable upside, analysts plainly believe Alcon is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63

Alcon has a net margin of 7.70% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Alcon's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Alcon 7.70%7.11%4.98%

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.26$374.90M$1.1858.06
Alcon$10.40B3.18$980M$1.6640.32

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 53.9% of Alcon shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Cooper Companies had 10 more articles in the media than Alcon. MarketBeat recorded 14 mentions for Cooper Companies and 4 mentions for Alcon. Cooper Companies' average media sentiment score of 0.89 beat Alcon's score of 0.59 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
Alcon
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a beta of 0.84, meaning that its share price is 16% less volatile than the broader market. Comparatively, Alcon has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

Alcon beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

West Pharmaceutical Services has a net margin of 16.85% compared to Cooper Companies' net margin of 5.57%. West Pharmaceutical Services' return on equity of 19.03% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.85% 19.03% 14.06%
Cooper Companies 5.57%10.88%7.27%

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

West Pharmaceutical Services has a beta of 1.16, suggesting that its share price is 16% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.84, suggesting that its share price is 16% less volatile than the broader market.

West Pharmaceutical Services currently has a consensus target price of $363.17, indicating a potential upside of 1.39%. Cooper Companies has a consensus target price of $81.85, indicating a potential upside of 19.47%. Given Cooper Companies' higher possible upside, analysts plainly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
2 Strong Buy rating(s)
3.00
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$3.07B8.23$493.70M$7.4847.88
Cooper Companies$4.09B3.26$374.90M$1.1858.06

In the previous week, Cooper Companies had 5 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 14 mentions for Cooper Companies and 9 mentions for West Pharmaceutical Services. Cooper Companies' average media sentiment score of 0.89 beat West Pharmaceutical Services' score of 0.73 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
5 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

West Pharmaceutical Services beats Cooper Companies on 11 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

In the previous week, Cooper Companies had 2 more articles in the media than Align Technology. MarketBeat recorded 14 mentions for Cooper Companies and 12 mentions for Align Technology. Cooper Companies' average media sentiment score of 0.89 beat Align Technology's score of 0.83 indicating that Cooper Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Align Technology
4 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cooper Companies
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Align Technology has higher earnings, but lower revenue than Cooper Companies. Align Technology is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Align Technology$4.03B3.17$410.35M$5.9629.94
Cooper Companies$4.09B3.26$374.90M$1.1858.06

Align Technology has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.84, suggesting that its stock price is 16% less volatile than the broader market.

Align Technology has a net margin of 10.50% compared to Cooper Companies' net margin of 5.57%. Align Technology's return on equity of 15.82% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Align Technology10.50% 15.82% 10.17%
Cooper Companies 5.57%10.88%7.27%

Align Technology presently has a consensus price target of $206.07, suggesting a potential upside of 15.47%. Cooper Companies has a consensus price target of $81.85, suggesting a potential upside of 19.47%. Given Cooper Companies' higher probable upside, analysts plainly believe Cooper Companies is more favorable than Align Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Align Technology
0 Sell rating(s)
5 Hold rating(s)
8 Buy rating(s)
2 Strong Buy rating(s)
2.80
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38

Summary

Align Technology beats Cooper Companies on 10 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Merit Medical Systems?

Cooper Companies (NASDAQ:COO) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

Merit Medical Systems has a net margin of 9.03% compared to Cooper Companies' net margin of 5.57%. Merit Medical Systems' return on equity of 13.54% beat Cooper Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
Merit Medical Systems 9.03%13.54%7.94%

Cooper Companies currently has a consensus target price of $81.85, indicating a potential upside of 19.47%. Merit Medical Systems has a consensus target price of $92.80, indicating a potential upside of 30.67%. Given Merit Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than Cooper Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
Merit Medical Systems
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cooper Companies has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.26$374.90M$1.1858.06
Merit Medical Systems$1.54B2.75$128.49M$2.3130.74

In the previous week, Cooper Companies had 10 more articles in the media than Merit Medical Systems. MarketBeat recorded 14 mentions for Cooper Companies and 4 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 1.17 beat Cooper Companies' score of 0.89 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
Merit Medical Systems
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cooper Companies has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

Summary

Merit Medical Systems beats Cooper Companies on 9 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to ICU Medical?

Cooper Companies (NASDAQ:COO) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Cooper Companies has higher revenue and earnings than ICU Medical. Cooper Companies is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cooper Companies$4.09B3.26$374.90M$1.1858.06
ICU Medical$2.23B1.72$730K$1.8582.97

Cooper Companies has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, ICU Medical has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

In the previous week, Cooper Companies had 9 more articles in the media than ICU Medical. MarketBeat recorded 14 mentions for Cooper Companies and 5 mentions for ICU Medical. Cooper Companies' average media sentiment score of 0.89 beat ICU Medical's score of 0.64 indicating that Cooper Companies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cooper Companies
8 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
ICU Medical
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 2.1% of ICU Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cooper Companies currently has a consensus target price of $81.85, suggesting a potential upside of 19.47%. ICU Medical has a consensus target price of $168.40, suggesting a potential upside of 9.71%. Given Cooper Companies' higher probable upside, analysts plainly believe Cooper Companies is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cooper Companies
3 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.38
ICU Medical
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
3 Strong Buy rating(s)
3.00

Cooper Companies has a net margin of 5.57% compared to ICU Medical's net margin of 2.15%. Cooper Companies' return on equity of 10.88% beat ICU Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Cooper Companies5.57% 10.88% 7.27%
ICU Medical 2.15%7.50%3.91%

Summary

Cooper Companies beats ICU Medical on 11 of the 17 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for COO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COO vs. The Competition

MetricCooper CompaniesMED/DENTAL IndustryMedical SectorNASDAQ Exchange
Market Cap$13.91B$16.75B$6.86B$12.44B
Dividend YieldN/A1.32%2.68%8.42%
P/E Ratio58.0619.0226.9624.38
Price / Sales3.262.36521.1991.92
Price / Cash11.7814.4048.5959.36
Price / Book1.653.3310.956.33
Net Income$374.90M$534.24M$3.59B$331.02M
7 Day Performance-1.58%1.67%-1.49%-0.33%
1 Month Performance1.11%3.84%2.75%-1.29%
1 Year Performance-5.11%3.35%28.51%21.30%

Cooper Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COO
Cooper Companies
3.2471 of 5 stars
$68.51
-3.9%
$81.85
+19.5%
-6.9%$13.91B$4.09B58.0615,000
ALC
Alcon
3.9046 of 5 stars
$67.87
+1.1%
$85.12
+25.4%
-23.4%$33.57B$10.40B40.8925,942
WST
West Pharmaceutical Services
2.9943 of 5 stars
$355.95
+0.6%
$355.55
-0.1%
+59.4%$25.08B$3.07B47.4610,800
ALGN
Align Technology
3.8142 of 5 stars
$177.02
+1.3%
$206.07
+16.4%
-10.5%$12.72B$4.03B29.8020,290
MMSI
Merit Medical Systems
4.1643 of 5 stars
$72.06
+0.8%
$92.80
+28.8%
-24.0%$4.30B$1.52B31.197,500

Related Companies and Tools


This page (NASDAQ:COO) was last updated on 7/15/2026 by MarketBeat.com Staff.
From Our Partners